论文部分内容阅读
武田药厂(日本武田药品工业株式会社)创立于1781年,现已成为日本最大的药厂,也是世界著名药厂之一。它在科学研究、生产和质量管理、市场开发和医药情报各方面都已达到国际水准。其销售额、经营利润和本期利润跃居日本30家制药大企业之首。此外,在研究和开发费用的投入上也居日本同行之首,1992年投入575亿日元,1993年达600亿日元(约合6亿美元)以上。 武田在战后从引进专利新药的许可证开始,逐步走向
Takeda Pharmaceutical Co., Ltd. (Japan Takeda Pharmaceutical Industry Co., Ltd.) was founded in 1781 and has now become Japan’s largest pharmaceutical company and one of the world’s leading pharmaceutical companies. It has reached international standards in all aspects of scientific research, production and quality management, market development and medical intelligence. Its sales, operating profits and profits for the current period topped the list of the top 30 pharmaceutical companies in Japan. In addition, it also ranks first among its Japanese counterparts in investing in research and development costs. It invested 57.5 billion yen in 1992 and reached 60 billion yen (about 600 million U.S. dollars) in 1993. Takeda started from the introduction of patents for new drugs and gradually